| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.37 | 1e-31 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-14 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.24 | 9e-13 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.21 | 3e-05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.18 | 3e-05 |